Kuick Research Report Highlights Ongoing Developments In Molecular Switches Application Therapeutic Targets & Drug Delivery ...

Results from a phase 1 study suggested that the CD70-directed allogeneic chimeric antigen receptor (CAR) T-cell therapy ... There were 28% of patients who experienced serious CRS. Immune effector cell ...

This study identifies 47,350 enhancers active in human neurons during differentiation and links some to genes involved in ...

Developing effective treatments and understanding how the mechanism of the immune system have always been challenging for ...

During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...